These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 31210718)

  • 1. Proton pump inhibitor use increases hepatic encephalopathy risk: A systematic review and meta-analysis.
    Ma YJ; Cao ZX; Li Y; Feng SY
    World J Gastroenterol; 2019 Jun; 25(21):2675-2682. PubMed ID: 31210718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of proton pump inhibitors with risk of hepatic encephalopathy in advanced liver disease: A meta-analysis.
    Tantai XX; Yang LB; Wei ZC; Xiao CL; Chen LR; Wang JH; Liu N
    World J Gastroenterol; 2019 Jun; 25(21):2683-2698. PubMed ID: 31210719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between proton pump inhibitors and hepatic encephalopathy: A meta-analysis.
    Bian J; Wang A; Lin J; Wu L; Huang H; Wang S; Yang X; Lu X; Xu Y; Zhao H
    Medicine (Baltimore); 2017 Apr; 96(17):e6723. PubMed ID: 28445288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton Pump Inhibitor Therapy and Hepatic Encephalopathy Risk in Cirrhotic Patients: A Systematic Review with Meta-analysis.
    Shi D; Zhou Z; Dai Y; Pan X; Cao Q
    Clin Drug Investig; 2019 Sep; 39(9):847-856. PubMed ID: 31183628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton pump inhibitor use increases mortality and hepatic decompensation in liver cirrhosis.
    De Roza MA; Kai L; Kam JW; Chan YH; Kwek A; Ang TL; Hsiang JC
    World J Gastroenterol; 2019 Sep; 25(33):4933-4944. PubMed ID: 31543684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients With Cirrhosis in A Population Study.
    Tsai CF; Chen MH; Wang YP; Chu CJ; Huang YH; Lin HC; Hou MC; Lee FY; Su TP; Lu CL
    Gastroenterology; 2017 Jan; 152(1):134-141. PubMed ID: 27639806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis.
    Trifan A; Stanciu C; Girleanu I; Stoica OC; Singeap AM; Maxim R; Chiriac SA; Ciobica A; Boiculese L
    World J Gastroenterol; 2017 Sep; 23(35):6500-6515. PubMed ID: 29085200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton Pump Inhibitors Increases Longitudinal Risk of Mortality, Decompensation, and Infection in Cirrhosis: A Meta-Analysis.
    Wong ZY; Koh JH; Muthiah M; Koh B; Ong EYH; Ong CEY; Ou KQ; Lim WH; Tan DJH; Chee D; Siah KTH; Wong Y; Kaewdech A; Wijarnpreecha K; Kulkarni AV; Nah B; Huang DQ; Noureddin M; Ng CH; Teng M
    Dig Dis Sci; 2024 Jan; 69(1):289-297. PubMed ID: 37968557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton pump inhibitor use does not increase dementia and Alzheimer's disease risk: An updated meta-analysis of published studies involving 642305 patients.
    Song YQ; Li Y; Zhang SL; Gao J; Feng SY
    PLoS One; 2019; 14(7):e0219213. PubMed ID: 31265473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton pump inhibitors use and dementia risk: a meta-analysis of cohort studies.
    Zhang Y; Liang M; Sun C; Song EJ; Cheng C; Shi T; Min M; Sun Y
    Eur J Clin Pharmacol; 2020 Feb; 76(2):139-147. PubMed ID: 31748819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton Pump Inhibitor Use Is Associated with an Increased Frequency of New or Worsening Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt Creation.
    Lewis DS; Lee TH; Konanur M; Ziegler C; Hall MD; Pabon-Ramos WM; Suhocki PV; Smith TP; Kim CY; Choi SS; Ronald J
    J Vasc Interv Radiol; 2019 Feb; 30(2):163-169. PubMed ID: 30638914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis: proton pump inhibitors moderately increase the risk of small intestinal bacterial overgrowth.
    Su T; Lai S; Lee A; He X; Chen S
    J Gastroenterol; 2018 Jan; 53(1):27-36. PubMed ID: 28770351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognosis and incidence of hepatic encephalopathy of patients with liver cirrhosis treated with proton pump inhibitors: A multicenter retrospective study in Japan.
    Sakamaki A; Kamimura K; Yokoo T; Osaki A; Yoshikawa S; Arao Y; Setsu T; Kamimura H; Waguri N; Takeuchi M; Funakoshi K; Terai S
    Medicine (Baltimore); 2021 Aug; 100(32):e26902. PubMed ID: 34397919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton pump inhibitor therapy and its association with spontaneous bacterial peritonitis incidence and mortality: A meta-analysis.
    Yu T; Tang Y; Jiang L; Zheng Y; Xiong W; Lin L
    Dig Liver Dis; 2016 Apr; 48(4):353-9. PubMed ID: 26795544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic encephalopathy with proton pump inhibitor use in post tips patients: a systematic review and meta-analysis.
    Gangwani MK; Ahmed Z; Ishtiaq R; Aziz M; Rani A; Dahiya DS; Priyanka F; Arif SF; Lee-Smith W; Sohail AH; Inamdar S; Hassan M
    Minerva Gastroenterol (Torino); 2024 Sep; 70(3):353-358. PubMed ID: 37889110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton pump inhibitor use is associated with increased rates of post-TIPS hepatic encephalopathy: Replication in an independent patient cohort.
    Dai R; Sag AA; Martin JG; Befera NT; Pabon-Ramos WM; Suhocki PV; Smith TP; Kim CY; Muir AJ; Ronald J
    Clin Imaging; 2021 Sep; 77():187-192. PubMed ID: 33940357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites.
    Dam G; Vilstrup H; Watson H; Jepsen P
    Hepatology; 2016 Oct; 64(4):1265-72. PubMed ID: 27474889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton-pump inhibitors use, and risk of acute kidney injury: a meta-analysis of observational studies.
    Yang Y; George KC; Shang WF; Zeng R; Ge SW; Xu G
    Drug Des Devel Ther; 2017; 11():1291-1299. PubMed ID: 28479851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton Pump Inhibitors Are Associated With Minimal and Overt Hepatic Encephalopathy and Increased Mortality in Patients With Cirrhosis.
    Nardelli S; Gioia S; Ridola L; Farcomeni A; Merli M; Riggio O
    Hepatology; 2019 Aug; 70(2):640-649. PubMed ID: 30289992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis.
    Janarthanan S; Ditah I; Adler DG; Ehrinpreis MN
    Am J Gastroenterol; 2012 Jul; 107(7):1001-10. PubMed ID: 22710578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.